PTGX (PROTAGONIST THERAPEUTICS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold PTGX (PROTAGONIST THERAPEUTICS INC) with a combined value of $969.98M across 11,105,753 shares. The largest holder is BlackRock, Inc. with a position worth $848.60M (0.01% of their portfolio). 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$969.98M
Total Shares Held
11,105,753
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $848.60M | 0.01% | +3.3% |
| 2 | CITADEL ADVISORS LLC | $106.72M | 0.02% | +353.8% |
| 3 | Duquesne Family Office LLC | $13.95M | 0.31% | - |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $713.31K | 0.00% | +0.0% |